Satellos Bioscience Inc. Opens the Market

TORONTO, May 15, 2024 /PRNewswire/ - Frank Gleeson Co-Founder and Chief Executive Officer, Satellos Bioscience Inc. (TSX: MSCL) ("Satellos" or the "Company"), and his team joined Dani Lipkin, Managing Director, Global Innovation Sector, Toronto Stock Exchange (TSX), to open the market and celebrate the Company's graduation to TSX.

Satellos is a publicly traded biotechnology company dedicated to developing life-improving medicines to treat degenerative muscle diseases. For more information, visit www.satellos.com.

CNW sponsored announcement. To learn more visit www.newswire.ca.

View original content to download multimedia:https://www.prnewswire.com/news-releases/satellos-bioscience-inc-opens-the-market-302146505.html

SOURCE Toronto Stock Exchange